Antibody-enhanced dengue virus infection in primate leukocytes.
about
Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapsePredicting outcome from dengueExtensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infectionPreparing for dengue vaccine introduction: recommendations from the 1st dengue v2V International MeetingVaccines for preventing dengue infectionPresent and future arboviral threatsDengue and dengue hemorrhagic feverAn in-depth analysis of original antigenic sin in dengue virus infectionMosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent EnhancementDC-SIGN (CD209) mediates dengue virus infection of human dendritic cellsDengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virusA role for IgG immune complexes during infection with the intracellular pathogen Leishmania.Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsDengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and TreatmentRole of microparticles in dengue virus infection and its impact on medical intervention strategiesSTAT2 signaling and dengue virus infectionSynergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1Replication in cells of hematopoietic origin is necessary for Dengue virus disseminationEarly T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.Infection of human cells by dengue virus is modulated by different cell types and viral strainsYellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse ModelAmerican Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic CellsEcological and immunological determinants of dengue epidemicsMurine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular PermeabilityPediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue VirusA Heterologous DNA Prime-Venezuelan Equine Encephalitis Virus Replicon Particle Boost Dengue Vaccine Regimen Affords Complete Protection from Virus Challenge in Cynomolgus MacaquesPrimary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In VitroEpitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized AntibodyDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibodyComplement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific MannerDetection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patientsInfection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement LevelsSubtype cross-reactive, infection-enhancing antibody responses to influenza A virusesRelationship between Transmission Intensity and Incidence of Dengue Hemorrhagic Fever in ThailandAntibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain IIImmunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitisAntibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1Macrophage Fc receptors control infectivity and neutralization of canine distemper virus-antibody complexesStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development
P2860
Q21144516-6FB6BF5B-C27F-4A26-8C7A-C92DE2DD64E5Q21146686-E3E41179-A3EC-4682-9522-6DF45016BEFEQ21245045-D88D0BEF-82F0-449A-AEF5-2F5CDB51F626Q21562244-E5E7E1F9-CD40-4533-B525-A15787F0C8DCQ24247907-65B3CAF0-5A71-40E1-B3AC-8A607FFB05C3Q24289450-AD13398D-4038-4E62-A123-367F0218DCC0Q24550739-0C7AF933-FEF3-4333-BD5A-E790576B9332Q24606493-17355D15-3E13-4F3D-973C-0A18D661669EQ24655645-A4D94BC6-045A-4533-9489-9C9B425FA81DQ24673466-3B16E479-B1EA-4735-8FAC-3DD378B78189Q24737245-C242D84C-AF1F-4484-B2B0-BF51CF1A171CQ25256801-43DBD419-C954-468E-A312-F0158AD55EE6Q26257542-482D3836-D25A-4EA7-89C3-A3E355046762Q26827164-CB4B7623-27E8-4181-B228-A9E45FDAB689Q26860307-EBE48D0E-C571-4BA1-ACC6-409A9DE5D98FQ27028229-91E43E19-ED38-4ECA-AFAD-7B343140E866Q27305534-450B45C8-1BDF-428F-B9A9-1703E03DE229Q27347892-510A702F-82B2-4BA6-9F93-5123FFC759E2Q27469477-445FB454-D5F4-4937-9923-62A7BE2F8769Q27469591-A351A944-83DB-4D1C-964C-247E12C02F6CQ27469687-159076DD-E337-4A15-9F63-300A94013E47Q27473317-5098671E-DE21-4063-90ED-7F7E0CC2BEB0Q27473379-D48D5673-F390-4CB4-88E1-C639171397E2Q27473480-65BD5D82-CA5C-409E-BDC2-20E2FEB136BCQ27477548-BFE79C64-6E7B-475A-A257-E8D72CC2D1D4Q27484362-B1EDDFD7-779C-468E-A69B-B9B7E13C7AAEQ27484994-9BC317EE-3DDC-4125-9550-CA9C94219C92Q27485010-B95A2FEE-8EEE-45F4-B59F-CBE22E2E61E5Q27485025-BD287613-F2C9-478B-BD54-5B5A368DC7ACQ27485050-7011B971-B7EB-409F-9D78-2EFB59D43B8EQ27485131-46792EEA-68CF-4D8F-A376-88DBF8DBA6A8Q27485151-475FC4A6-4DA5-4C29-A3DF-158EA0AAF8A8Q27485321-C19110CA-2644-49EB-B03F-19A5555FE305Q27485986-565D2FFD-B208-44B7-BBA8-6F00A8730EDDQ27486395-1CB52EC3-1F4A-480C-B676-A7A4469BB7C7Q27486409-A9C68C60-A87B-4E6A-A221-7C63314844F3Q27486490-6161DF92-8EA9-4451-8CAD-684EDECD7DF4Q27486610-AD4BD3DD-7FDA-483C-88E3-E8CF9E18624DQ27486994-E57E5911-82DE-4077-99CA-07C17EF4BB87Q27488364-9BB06697-72C8-4E88-BD53-53EBA29D6B78
P2860
Antibody-enhanced dengue virus infection in primate leukocytes.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Antibody-enhanced dengue virus infection in primate leukocytes.
@en
type
label
Antibody-enhanced dengue virus infection in primate leukocytes.
@en
prefLabel
Antibody-enhanced dengue virus infection in primate leukocytes.
@en
P356
P1433
P1476
Antibody-enhanced dengue virus infection in primate leukocytes.
@en
P2093
O'Rourke EJ
P2888
P304
P356
10.1038/265739A0
P407
P577
1977-02-01T00:00:00Z
P6179
1025513105